Search Results - Han, Shuiyun

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Long non‐coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA‐125a in multiple myeloma

    Long non‐coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA‐125a in multiple myeloma by Yu, Haifeng, Peng, Shuailing, Chen, Xi, Han, Shuiyun, Luo, Jialin

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms

    Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms by Yu, Haifeng, Peng, Shuailing, Han, Shuiyun, Chen, Xi, Lyu, Qinghua, Lei, Tao

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo

    Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo by Jiang, Chenxue, Han, Shuiyun, Sun, Xiaojiang, Xu, Yaping, Feng, Jianguo, Shang, Jinbiao

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma

    A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma by Sun, Xiaojiang, Han, Shuiyun, Gu, Feiying, Lin, Gang, Wang, Zhun, Wang, Yuezhen, Xu, Yaping

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    The Prognostic Utility of (18)F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients

    The Prognostic Utility of (18)F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Ce... by Li, Cong, Yu, Haifeng, Chen, Xi, Han, Shuiyun, Peng, Shuailing, Lei, Tao, Yang, Haiyan

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy

    Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy by Li, Cong, Lu, Fangxiao, Lei, Tao, Yu, Haifeng, Chen, Xi, Peng, Shuailing, Han, Shuiyun, Yang, Haiyan

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer

    A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer by Jiang, Chenxue, Han, Shuiyun, Chen, Wucheng, Ying, Xiaozhen, Wu, He, Zhu, Yaoyao, Shi, Guodong, Sun, Xiaojiang, Xu, Yaping

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study

    Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy... by Hu, Min, Xu, Qinghua, Yang, Shuangyan, Han, Shuiyun, Zhu, Yaoyao, Lin, Qingren, Sun, Xiaojiang, Liu, Hui, Xu, Yaping

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Bruton’s tyrosine kinase inhibitors in primary central nervous system lymphoma—evaluation of anti-tumor efficacy and brain distribution

    Bruton’s tyrosine kinase inhibitors in primary central nervous system lymphoma—evaluation of anti-tumor efficacy and brain distribution by Yu, Haifeng, Kong, Haiying, Li, Cong, Dong, Xiaowu, Wu, Yizhe, Zhuang, Yuxin, Han, Shuiyun, Lei, Tao, Yang, Haiyan

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma

    High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma by Chen, Xi, Kong, Haiying, Luo, Linxiang, Han, Shuiyun, Lei, Tao, Yu, Haifeng, Guo, Na, Li, Cong, Peng, Shuailing, Dong, Xiaowu, Yang, Haiyan, Wu, Meijuan

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: